when is retatrutide coming out Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide FDA Approval Status 2026:

This quells inflammation, speeds the healing of skin flaps (sections of skin that are lifted up and separated from their blood supply during surgery), and boosts fat survival (in cases of fat grafting, where fat is taken from one part of the body and transferred to another)

In a 2019 in vivo study, Attanzio et al

In one 2002 paper published in the Journal of Gerontology: Medical Sciences, researchers conducted a meta-analysis examining the relationship between low B12 levels and continence in older people

56 , and Arkal et al

This projects approval around Q3 2027 under an optimistic priority-review scenario, or Q1Q2 2028 under standard review